Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human skin barrier, primarily located in the stratum corneum, consists of a brick and mortar structure where keratin-filled corneocytes (bricks) are embedded in a complex lipid matrix (mortar) composed of ceramides, cholesterol, and free fatty acids (StatPearls, 2023). This barrier is essential for preventing excessive transepidermal water loss and protecting the body from environmental pathogens, allergens, and chemical irritants (PubMed, PMID: 18306158). Keratins provide structural integrity and mechanical strength to the epidermis, while the lipid lamellae ensure permeability control (UniProt, P04264). Dysregulation or depletion of these components is a hallmark of inflammatory skin diseases such as atopic dermatitis and psoriasis, where the barrier is compromised (NIH, 2021). Therapeutic interventions often target this barrier through the application of emollient lipids to restore the matrix or keratolytic agents to modulate the shedding of keratinized cells (Journal of Clinical Medicine, 2022). Understanding the interplay between these lipids and proteins is crucial for developing effective topical delivery systems and barrier-repairing formulations (Wikipedia, Stratum corneum).
Therapeutic agents interact with the skin barrier through several mechanisms: occlusion (forming a physical film to prevent water loss), humectancy (drawing water into the stratum corneum), emolliency (filling gaps between corneocytes with lipids), and keratolysis (breaking down keratin aggregates to facilitate desquamation).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human skin barrier lipids and keratin (SC barrier).